{
    "nct_id": "NCT02894645",
    "official_title": "Ma-Spore ALL 2010 Study",
    "criteria": {
        "raw_text": "Inclusion Criteria:\n\n1. Confirmed diagnosis of non-Burkitt B-lineage ALL\n2. 1 to 17 years of age (before 18th birthday)\n3. Renal function within normal range for age\n4. Liver function within normal range for age\n5. Able to participate in the full 2 years of treatment\n\nExclusion Criteria:\n\n1. Age less than one year or age greater than/equals to 18 years\n2. Previous treatment with cytotoxic agents or high-dose steroids\n3. Mixed phenotype acute leukemia (MPAL)\n4. ALL as secondary malignancy\n5. Abnormal renal or liver function\n6. Doubtful compliance or unable to afford full course of therapy\n\nsex: ALL\n\nminimumAge: 1 Year\n\nmaximumAge: 17 Years\n\nstdAges: ['CHILD']",
        "inclusion": "1. Confirmed diagnosis of non-Burkitt B-lineage ALL\n2. 1 to 17 years of age (before 18th birthday)\n3. Renal function within normal range for age\n4. Liver function within normal range for age\n5. Able to participate in the full 2 years of treatment",
        "exclusion": "1. Age less than one year or age greater than/equals to 18 years\n2. Previous treatment with cytotoxic agents or high-dose steroids\n3. Mixed phenotype acute leukemia (MPAL)\n4. ALL as secondary malignancy\n5. Abnormal renal or liver function\n6. Doubtful compliance or unable to afford full course of therapy"
    }
}